The report provides a detailed analysis essential for establishing an Oxaprozin production plant. It encompasses all critical aspects necessary for Oxaprozin production, including the cost of Oxaprozin production, Oxaprozin plant cost, Oxaprozin production costs, and the overall Oxaprozin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Oxaprozin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Oxaprozin is a nonsteroidal anti-inflammatory drug (NSAID) that reduces cyclooxygenase (COX) enzymes to decrease prostaglandin levels responsible for pain, fever, and inflammation. It manages osteoarthritis symptoms in adults by reducing joint pain, stiffness, and swelling to enhance mobility.
It treats rheumatoid arthritis by easing chronic joint tenderness and inflammation. It controls juvenile rheumatoid arthritis flares in children over 6 years old with a safer GI profile than some NSAIDs. It also helps in relieving ankylosing spondylitis spinal rigidity, acute gout swelling, postoperative dental pain, soft tissue injuries like sprains, and mild-to-moderate general pain or fever. But it requires caution due to potential cardiovascular, renal, or gastrointestinal risks common to NSAIDs.
The market for Oxaprozin is driven by rising global cases of arthritis, osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. The rise in ageing populations contributes to its demand as a long-lasting pain relief solution with once-daily dosing.
The innovations in delivery systems and regulatory approvals for advanced formulations further expand its applications. The industrial Oxaprozin procurement is influenced by high capital needs for API production facilities, strict regulatory compliance, and supply chain vulnerabilities like overreliance on a single API or FPP sites. Other factors, like production and quality issues, and geopolitical disruptions, affect its sourcing.
Raw Material for Oxaprozin Production
According to the Oxaprozin production plant project report, the key raw materials used in the production of Oxaprozin include Succinic Anhydride, Benzoin, and Pyridine.
Production Process of Oxaprozin
The extensive Oxaprozin production cost report consists of the following major industrial production process:
- From Succinic Anhydride: The production process of Oxaprozin involves several steps. In this process, succinic anhydride, benzoin, and pyridine are added to the reaction vessel under nitrogen. The mixture is heated to 90-95 degree Celsius and stirred for 1.5 hours, followed by adding glacial acetic acid and ammonium acetate. The mixture is filtered with a glacial acetic acid rinse, and distilled water is added. After filtration and washing, the product is slurried with distilled water, filtered, washed with distilled water, and dried to get Oxaprozin as the final product.
Oxaprozin is a white to off-white powder with a slight odour. It has a molecular formula C18H15NO3, and a molecular weight of 293.32 g/mol. It has a melting point between 158 and 163 degree Celsius. It is insoluble in water but slightly soluble in alcohol. It has a logP of around 4.19 that makes it highly lipophilic. It has an octanol/water partition coefficient of 4.8 at pH 7.4, and a pKa of 4.3. It has a propionic acid-based structure with an oxazole ring fused to a benzoxazole system. It shows saturable plasma protein binding (>99.5% to albumin), a volume of distribution of 11-17 L/70 kg, and stability requiring storage at -20 degree Celsius or controlled conditions.
